These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26369899)

  • 1. Bisphosphonates for preventing bone disease in kidney transplant recipients: a meta-analysis of randomized controlled trials.
    Versele EB; Van Laecke S; Dhondt AW; Verbeke F; Vanholder R; Van Biesen W; Nagler EV
    Transpl Int; 2016 Feb; 29(2):153-64. PubMed ID: 26369899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for preventing bone disease in kidney transplant recipients.
    Palmer SC; McGregor DO; Strippoli GF
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005015. PubMed ID: 17636784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for preventing bone disease in kidney transplant recipients.
    Palmer S; McGregor DO; Strippoli GF
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005015. PubMed ID: 15846740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Bisphosphonates for Low Bone Mineral Density After Kidney Transplantation: A Meta-Analysis.
    Kan SL; Ning GZ; Chen LX; Zhou Y; Sun JC; Feng SQ
    Medicine (Baltimore); 2016 Feb; 95(5):e2679. PubMed ID: 26844505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates for prevention of osteopenia in kidney-transplant recipients: a systematic review of randomized controlled trials.
    Wang J; Yao M; Xu JH; Shu B; Wang YJ; Cui XJ
    Osteoporos Int; 2016 May; 27(5):1683-90. PubMed ID: 26733377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials.
    Palmer SC; Strippoli GF; McGregor DO
    Am J Kidney Dis; 2005 Apr; 45(4):638-49. PubMed ID: 15806466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bisphosphonates on bone loss in the first year after renal transplantation--a meta-analysis of randomized controlled trials.
    Mitterbauer C; Schwarz C; Haas M; Oberbauer R
    Nephrol Dial Transplant; 2006 Aug; 21(8):2275-81. PubMed ID: 16574684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonates for osteoporosis in primary biliary cirrhosis.
    Rudic JS; Giljaca V; Krstic MN; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2011 Dec; (12):CD009144. PubMed ID: 22161446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of bisphosphonate and its supplements for bone loss in kidney transplant recipients: a systematic review and network meta-analysis.
    Yang Y; Qiu S; Deng L; Tang X; Li X; Wei Q; Fu P
    BMC Nephrol; 2018 Oct; 19(1):269. PubMed ID: 30340537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of bisphosphonate therapy in kidney transplant recipients: a systematic review and meta-analysis.
    Toth-Manikowski SM; Francis JM; Gautam A; Gordon CE
    Clin Transplant; 2016 Sep; 30(9):1090-6. PubMed ID: 27327448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Different Bisphosphonates for Bone Loss Prevention in Kidney Transplant Recipients: A Network Meta-Analysis of Randomized Controlled Trials.
    Yang Y; Qiu S; Tang X; Li XR; Deng LH; Wei Q; Fu P
    Chin Med J (Engl); 2018 Apr; 131(7):818-828. PubMed ID: 29578126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Bisphosphonates for Osteoporosis or Osteopenia in Cardiac Transplant Patients: A Meta-Analysis.
    Zhao J; Wang C; Hu Z
    Transplant Proc; 2015 Dec; 47(10):2957-64. PubMed ID: 26707321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of medical therapy for low bone mineral density in patients with inflammatory bowel disease: a meta-analysis and systematic review.
    Melek J; Sakuraba A
    Clin Gastroenterol Hepatol; 2014 Jan; 12(1):32-44.e5. PubMed ID: 23981521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of bisphosphonates against osteoporosis in adult men: a meta-analysis of randomized controlled trials.
    Chen L; Wang G; Zheng F; Zhao H; Li H
    Osteoporos Int; 2015 Sep; 26(9):2355-63. PubMed ID: 25944731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates for breast cancer.
    Pavlakis N; Stockler M
    Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and management of bone disease and fractures post transplant.
    Bia M
    Transplant Rev (Orlando); 2008 Jan; 22(1):52-61. PubMed ID: 18631858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone disease in organ transplant patients: pathogenesis and management.
    Chauhan V; Ranganna KM; Chauhan N; Vaid M; Kelepouris E
    Postgrad Med; 2012 May; 124(3):80-90. PubMed ID: 22691902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of bisphosphonates on bone mineral density in liver transplant patients: a meta-analysis and systematic review of randomized controlled trials.
    Kasturi KS; Chennareddygari S; Mummadi RR
    Transpl Int; 2010 Feb; 23(2):200-7. PubMed ID: 19793074
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.